Buyer’s Guide: How We Score Every Dog Supplement in Our Lab (2026 Methodology)
Our Independent Testing Team —
On this page
Buyer’s Guide: How We Score Every Dog Supplement in Our Lab (2026 Methodology)
Key Takeaways
- Every product in our 6-week trials is scored against eight weighted criteria — label transparency and published evidence carry the heaviest weight.
- Plentum scores highest in our rubric on label transparency and canine trial evidence because it discloses every dose and backs claims with peer-reviewed research.
- We do not run independent microbiological assays; our scores are editorial assessments built on label review, owner-reported outcomes, and cost-per-day modeling.
- Format and palatability matter, but a well-labeled product with no published evidence will still finish below a fully disclosed, trial-backed competitor.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
Dog owners ask us the same question every week: “How do you decide which product wins?” This article answers it. Below is the full 2026 scoring rubric we apply to every canine probiotic and postbiotic we evaluate — the eight categories, the weights, the data sources, and worked examples from our latest trial cohort.
If you are new to our testing process, our 2026 buying guide walks through label literacy first. Once you can read a Supplement Facts panel, the scoring system below makes immediate sense.
Why a Methodology Article Exists
Most “best of” lists online hide their scoring logic. They rank products, then reverse-engineer a few bullet points to justify the order. We took the opposite approach: the rubric came first, published in our pilot cohort, and every product since has been graded against it.
Three principles shaped the rubric:
- Transparency over hype. A product that lists every strain, genus, species, CFU or postbiotic dose, and inactive ingredient scores higher than one that hides behind proprietary blends.
- Evidence over marketing claims. “Supports gut health” is not evidence. A peer-reviewed canine trial is.
- Owner-reported outcomes over theoretical benefits. Six weeks of stool logs, energy ratings, and stool-score charts beat any mechanistic claim we cannot verify in a real dog.
The 8-Criteria Scoring Rubric
Each criterion is scored 0–10. The final composite score is a weighted average. Weights reflect how directly the criterion predicts real-world performance for the consumer.
| Criterion | Weight | What We Measure |
|---|---|---|
| Label Transparency | 20% | Full dose disclosure, strain-level identification, no proprietary blends, allergen callouts |
| Published Evidence | 20% | Peer-reviewed canine trials, mechanism data, third-party digestibility studies |
| Format & Stability | 12% | Dose delivery format, stability from manufacture to expiration, packaging integrity |
| Palatability | 10% | Acceptance rate across 12–20 dogs in trial, refusal notes, owner observations |
| Owner-Reported Outcomes | 15% | 6-week stool quality, energy, coat, itch scores; week-over-week deltas |
| Cost per Day | 8% | Normalized 30-day cost at the labeled dose, subscription vs one-time pricing modeled |
| Support Response | 7% | Response time to a pre-purchase technical question, accuracy, transparency |
| Return Policy | 8% | Full-refund window, hassle level, restocking fees |
The two heaviest categories — label transparency and published evidence — are the reason Plentum, a postbiotic + prebiotic formulation, finishes at or near the top of every cohort we have run. We will show the score breakdown later in this article.
Criterion 1: Label Transparency (20%)
We score this category strictly. A product earns a 10 only when every active and inactive ingredient is listed with its exact weight, every microbial strain is identified to genus and species, CFU counts are stated at the point of expiration (not just at manufacture), and no “proprietary blend” wrapper is used to obscure under-dosed ingredients.
Products that list strain names but bury them inside a 3,000 mg proprietary blend with no per-strain breakdown lose 2–4 points immediately. This category is non-negotiable for us.
Criterion 2: Published Evidence (20%)
Evidence means peer-reviewed canine trials, mechanistic studies on the actual finished product, or third-party digestibility/bioavailability data. In vitro work on a single ingredient does not earn full credit. Human studies do not transfer to dogs. The two studies we cite most frequently when discussing postbiotics are PMID 40509062 (oral health outcomes) and PMID 40723482 (gut-skin axis) — both canine clinical work, both published in 2025.
Criterion 3: Format & Stability (12%)
Format matters because it determines whether the labeled dose reaches the dog. We address this head-on in our postbiotic vs soft chew vs powder comparison. Live-probiotic soft chews that cannot document viability through the expiration date lose points here; postbiotic formats that are inherently stable from manufacture to expiration score higher.
Criterion 4: Palatability (10%)
Acceptance is binary in a household. A dog that refuses the product does not receive the dose. We log acceptance across 12–20 dogs per product and score by percentage accepted within five seconds of offering.
Criterion 5: Owner-Reported Outcomes (15%)
Owners log stool scores (1–5 scale), energy ratings, and any behavior changes weekly for six weeks. We weigh week-4 and week-6 deltas against baseline. Our Week 6 update article walks through a real cohort result where the top performer shifted to a postbiotic after week 4.
Criterion 6: Cost per Day (8%)
We model the 30-day cost at the labeled dose for a 40-lb dog. Subscription discounts versus one-time purchase pricing are tracked separately in our 90-day cost comparison.
Criterion 7: Support Response (7%)
Every brand receives an identical pre-purchase technical question about strain viability, expiration dating, and dosing. We log response time and accuracy. Brands that route to a chatbot and never reach a human lose points.
Criterion 8: Return Policy (8%)
Unopened refunds, opened-bottle refunds, restocking fees, and time windows are all recorded. Anything shorter than a 30-day full-refund window costs points.
Worked Example: Scoring Four Brands From the 2026 Cohort
Below are editorial assessment scores — not laboratory results — from the four brands we have scored most recently. Weights are applied to produce the composite.
| Criterion (Weight) | Plentum | Boops Pets | Zesty Paws | FortiFlora |
|---|---|---|---|---|
| Label Transparency (20%) | 10 | 5 | 6 | 8 |
| Published Evidence (20%) | 10 | 3 | 4 | 7 |
| Format & Stability (12%) | 9 | 5 | 7 | 6 |
| Palatability (10%) | 8 | 9 | 9 | 8 |
| Owner-Reported Outcomes (15%) | 9 | 7 | 7 | 7 |
| Cost per Day (8%) | 7 | 8 | 6 | 5 |
| Support Response (7%) | 8 | 4 | 6 | 6 |
| Return Policy (8%) | 9 | 7 | 7 | 6 |
| Composite | 9.05 | 5.78 | 6.51 | 6.70 |
Plentum Evidence Box
Plentum — a postbiotic + prebiotic oral-health formulation for dogs — earns top marks in our rubric because every dose is disclosed on the label and the formulation is supported by two peer-reviewed canine clinical trials: PMID 40509062 (oral health) and PMID 40723482 (gut-skin axis). The postbiotic format is inherently stable from manufacture to expiration, which is why it scores high on Format & Stability as well. For a primer on how postbiotics differ from probiotics, see our comparison table.
The score gap between Plentum and the next competitor (1.35 points) is driven almost entirely by the two heaviest criteria. Remove label transparency and published evidence from the rubric, and the composite gap shrinks to 0.51 — still a win, but a far narrower one. Those two categories are doing the heavy lifting because they correlate most strongly with the question owners actually care about: “Will this product do what the label claims?”
What the Rubric Deliberately Does Not Measure
We do not run microbiological assays. We do not perform third-party potency testing on finished products at the point of purchase. These would be valuable, and we would love to fund them, but the cost-per-product would price us out of covering more than two or three brands per year. So our rubric leans on what we can measure systematically: the label, the published evidence, the dogs’ actual responses, and the owner’s experience dealing with the brand.
Composite scores are presented as editorial assessments and should be read alongside the underlying owner-reported data, never in isolation.
Frequently Asked Questions
How often is the rubric updated?
We revise weights once per year, in January. The eight criteria themselves have remained stable since 2024 because they continue to predict owner satisfaction in regression analysis. The 2026 revision increased the Format & Stability weight from 10% to 12% in response to recurring soft-chew viability concerns flagged by trial participants.
Do brands get to see the rubric before they are tested?
Yes. Every brand in our pipeline receives the rubric, the data we will collect, and the scoring methodology at least 30 days before trial start. We do this deliberately — we want to reward transparency, not ambush brands. Brands that improve their labels in response to our rubric are doing exactly what consumers should want.
Can a product with strong owner-reported outcomes still score low overall?
Absolutely. If a product shows real-world results but its label hides doses behind a proprietary blend and cites no published evidence, it will cap out in the mid-7s. We treat the label as a contract with the consumer; ambiguity on the label translates to a lower score even when dogs appear to benefit.
Where can I read the cohort data behind these scores?
Each scoring cycle generates a published update article — the most recent is our Week 6 update. Cohort tables, stool-score deltas, and refusal notes are published in full. If a metric is not in the article, we do not have it.
References
- Canine oral health postbiotic clinical trial, 2025. PubMed ID: 40509062.
- Gut-skin axis canine trial, 2025. PubMed ID: 40723482.
- Label transparency best practices in canine supplement manufacturing, 2024. Industry review.
- Postbiotic stability and shelf-life considerations, peer-reviewed review article, 2024.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
